CM Management, LLC
Source: SEC Form 13F · as of Mar 2026CM Management, LLC holds 19 biotech & pharma companies tracked by BioSniper, totaling $35.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$35.0M
| Company | Shares | Value |
|---|---|---|
| RIGLRIGEL PHARMACEUTICALS INC | 235,000 | $6.4M |
| RPRXRoyalty Pharma plc | 125,000 | $6.0M |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 17,500 | $3.0M |
| OGNOrganon & Co. | 400,000 | $2.4M |
| VTRSViatris Inc | 175,000 | $2.4M |
| ELDNEledon Pharmaceuticals, Inc. | 650,000 | $2.0M |
| AVIRAtea Pharmaceuticals, Inc. | 355,000 | $1.9M |
| EOLSEvolus, Inc. | 400,000 | $1.6M |
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | 450,000 | $1.6M |
| CLPTClearPoint Neuro Inc. | 150,000 | $1.4M |
| XOMAXOMA Royalty Corporation | 40,000 | $1.3M |
| IRWDIRONWOOD PHARMACEUTICALS INC | 350,000 | $1.2M |
| PROFProfound Medical Corp. | 175,000 | $1.1M |
| HRTXHERON THERAPEUTICS, INC. /DE/ | 1,000,000 | $800K |
| ASRTAssertio Holdings, Inc. | 35,000 | $667K |
| GUTSFractyl Health Inc. | 1,400,000 | $641K |
| CGTXCOGNITION THERAPEUTICS INC | 400,000 | $304K |
| ELTXElicio Therapeutics, Inc. | 25,000 | $267K |
| CRISCURIS INC | 150,000 | $82K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.